she/her
Jill Rosenthal is the director of Public Health Policy at the Center for American Progress, where she works with other experts at CAP to develop and advance bold solutions to address structural public health issues and tackle health disparities through a social determinants of health framework. Before joining CAP, she served from 2000 to 2021 as senior program director at the National Academy for State Health Policy (NASHP), where she led NASHP’s population health portfolio, conducting research and policy analyses and providing technical assistance to states on identifying financial models to support population health improvement, building communities of practice, documenting best practices, and providing consultation as states developed models for nationwide spread. Rosenthal has a background in public health and health policy development, health promotion, and evaluation. She is a graduate of Colgate University and holds a master’s in public health from the University of North Carolina.
The federal government can make it easier and more affordable for individuals to reduce their own COVID-19 risk and take action to support public health.
Jill Rosenthal outlines next steps that the Biden administration, state and local policymakers, and private companies should take to prevent a winter surge in COVID-19 cases.
The House-passed bill expands insurance coverage, reduces prescription drug costs, and makes crucial investments in maternal and public health.
Jill Rosenthal discusses the efficacy of COVID-19 vaccine mandates.
By addressing key priorities, the budget reconciliation process can advance health and economic recovery and deliver benefits to the individuals, neighborhoods, and communities that need them the most.
Ensuring a quality education for America’s students during the COVID-19 pandemic will require a range of federal and state supports, as well as efforts to build a robust economy that works for everyone.
The Centers for Medicare and Medicaid Services should make COVID-19 vaccination mandatory for providers participating in Medicare and Medicaid, as this action would protect vulnerable patients, set a positive example for other employers, and contribute to the national effort to contain the virus.
Authors Jill Rosenthal and Ben Hatt commend the United States’ vaccine rollout and explain what must be done to ensure its continued success in the months ahead.
